Gaetan Duport: A New Legislation for Medicines in Europe
Gaetan Duport, Economic and Public Health Committee (CEESP), user representative at Haute Autorité de Santé, reposted from EU Health and Food Safety on LinkedIn:
”A new step forward with the pharma package : a new legislation for medicines in Europe.
A key milestone for better access to treatement.”
Quoting EU Health and Food Safety‘s post:
”Major reform of EU pharmaceutical rules agreed!
We welcome the political agreement reached on the pharma reform last night, which is a crucial step in boosting innovation and investment in the EU’s pharma sector.
The main aim of the new rules is to make sure that medicines in the EU are safe, effective and available to all patients in Europe.
Amongst other things, the rules will:
- Expand access and availability of medicines
- Accelerate medicine supply chains – by cutting red pate for companies and reducing evaluation times for new medicines by the EMA.
- Place the EU at the forefront of pharmaceutical innovation – by offering world-leading incentives for innovative products.
- Allow for speedy market access for generic medicines
- Address medicine shortages
The new rules are complemented by the Critical Medicines’ Act proposal, the recent Life Sciences Strategy and the upcoming Biotech Act.
Check out the factsheet below for more information about the key elements of the reform
For more information.”
Stay updated with Hemostasis Today.
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention
-
Jan 13, 2026, 05:05Pablo Corral Shares Key Takeaways on Reducing LDL-Cholesterol to Very Low Levels
-
Jan 13, 2026, 04:49Martin Haluzík Shares A Study on GLP1-1RAs Use in Peripheral Artery Disease and DM
-
Jan 13, 2026, 04:37Shreya Agarwal and Bryce A Kerlin on The Impact of Advanced Hemostasis and Thrombosis Fellowship Trainings
-
Jan 13, 2026, 03:53Christian Schulze Shares New Data from DANGERSHOCK
-
Jan 13, 2026, 03:39Samwel Mikaye Breaks Down Peripheral Blood Smear
-
Jan 12, 2026, 20:15Mazou Ngou Temgoua on SCAF: Subclinical Atrial Fibrillation on Treatment with Apixaban or Aspirin